Israel

5WPR Further Expands Israel Practice Area

Retrieved on: 
Monday, December 13, 2021

NEW YORK, Dec. 13, 2021 /PRNewswire/ --5W Public Relations, one of the largest independently-owned PR firms in the U.S., announces today the expansion of their dedicated Israel PR practice after announcing unprecedented growth earlier this year.

Key Points: 
  • NEW YORK, Dec. 13, 2021 /PRNewswire/ --5W Public Relations, one of the largest independently-owned PR firms in the U.S., announces today the expansion of their dedicated Israel PR practice after announcing unprecedented growth earlier this year.
  • The agency is a leading provider of PR and digital services for Israeli companies launching or looking to extend their reach in North America.
  • 5W's Israeli client roster includes several high-growth companies including HiBob, SodaStream, MySizeID, Lumenis, Carbyne, and AccessiBe.
  • "As we continue to grow within this space, our teams have become highly specialized in elevating brand image and guiding them through their US expansions," said 5WPR Founder and CEO, Ronn Torossian .

BioMilk Rebrands as Wilk

Retrieved on: 
Monday, December 13, 2021

REHOVOT, Israel, Dec. 13, 2021 /PRNewswire/ -- Bio-FoodTech startup Wilk today officially unveiled its new brand, including the change of its name from BioMilk.

Key Points: 
  • REHOVOT, Israel, Dec. 13, 2021 /PRNewswire/ -- Bio-FoodTech startup Wilk today officially unveiled its new brand, including the change of its name from BioMilk.
  • Wilk is leading the Revolution of Milk by developing an industrial process for producing both human and animal milk from milk-producing mammary epithelial cells.
  • "We see a unique opportunity for our company to stand at the vanguard of the Revolution of Milk, working with other key players for the benefit of humanity, thus our decision to rebrand from BioMilk to Wilk," said Tomer Aizen, CEO of Wilk.
  • Wilk is publicly traded on the Tel Aviv Stock Exchange under the ticker symbol WILK.

Nayya's Revenue Surges 7x, Capping Milestone Year for Innovative Benefits Personalization Company

Retrieved on: 
Monday, December 13, 2021

In 2021, Nayya registered an impressive sevenfold growth in annual revenue, compared to 2020.

Key Points: 
  • In 2021, Nayya registered an impressive sevenfold growth in annual revenue, compared to 2020.
  • "Nayya's rapid revenue growth underscores the power of data towards empowering employee benefits choices," said Saiba Sabherwal, Nayya's CFO.
  • We believe world-class data infrastructure is integral to building an agile and innovative company like Nayya."
  • The past year also marked a year of other important financial milestones and increased recognition for the growing company.

Better Juice is Going Commercial with Sugar Reduction Deal

Retrieved on: 
Monday, December 13, 2021

REHOVOT, Israel, Dec. 13, 2021 /PRNewswire/ -- FoodTech start-up Better Juice, Ltd. sealed its first commercial deal to bring reduced-sugar juices one step closer to supermarket beverage aisles.

Key Points: 
  • REHOVOT, Israel, Dec. 13, 2021 /PRNewswire/ -- FoodTech start-up Better Juice, Ltd. sealed its first commercial deal to bring reduced-sugar juices one step closer to supermarket beverage aisles.
  • The company inked an agreement with a major US fruit juice manufacturer for commercial installment of its sugar-reduction technology.
  • "Better Juice has incredible potential to transform the global juice industry," notes Colm O'Gorman, Head of Sales Management for GEA's Global Technology Center for Non-Alcoholic Beverages.
  • Better Juice has developed a groundbreaking solution that naturally reduces the amount of sugar in fresh juice drinks by up to 80 percent, without affecting its nutritional value or taste.

BrainStorm Cell Therapeutics Announces peer reviewed publication of NurOwn's® Phase 3 Study for ALS in Muscle and Nerve

Retrieved on: 
Monday, December 13, 2021

NEW YORK, Dec. 13, 2021 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of cellular therapies for neurodegenerative diseases, today announced the peer reviewed publication of Phase 3 clinical data in Muscle and Nerve.

Key Points: 
  • NEW YORK, Dec. 13, 2021 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of cellular therapies for neurodegenerative diseases, today announced the peer reviewed publication of Phase 3 clinical data in Muscle and Nerve.
  • "There are both biological and clinical signals of a treatment effect as a community, we must review these carefully.
  • Understanding how to use biomarkers to tailor treatments, like NurOwn, is an essential new direction in ALS therapy development."
  • About BrainStorm Cell Therapeutics Inc.
    BrainStorm Cell Therapeutics Inc. is a leading developer of innovative autologous adult stem cell therapeutics for debilitating neurodegenerative diseases.

My Size Announces It Has Reached Agreement Resolving Litigation with Todd Ault

Retrieved on: 
Friday, December 10, 2021

This proprietary measurement technology is driven by several algorithms that are able to calculate and record measurements in a variety of novel ways.

Key Points: 
  • This proprietary measurement technology is driven by several algorithms that are able to calculate and record measurements in a variety of novel ways.
  • To learn more about My Size, please visit our website: www.mysizeid.com .
  • This press release contains certain forward-looking statements within the meaning of the safe harbour provisions of the Private Securities Litigation Reform Act of 1995.
  • Forward-looking statements also are affected by the risk factors described in the Company's filings with the U.S. Securities and Exchange Commission.

Doctors from Israel and Gaza Work Across Borders to Save the Life of a Gazan Child

Retrieved on: 
Friday, December 10, 2021

During the first few weeks of his life, doctors in Gaza diagnosed the child with a complicated congenital heart condition that would require multiple medical procedures to save his life.

Key Points: 
  • During the first few weeks of his life, doctors in Gaza diagnosed the child with a complicated congenital heart condition that would require multiple medical procedures to save his life.
  • As he grew older it became more difficult for him to breathe and he needed emergency surgery to survive.
  • Two doctors in Gaza, Dr Abdalraheem Said and Dr. Hany Al Faleet, are responsible for screening all Gazan pediatric cardiac patients from the southern area of Gaza at the European Gaza Hospital.
  • In Israel, Mazen was treated at the SACH International Pediatric Cardiac Care Center at the new Sylvan Adams Children's Hospital.

Plarium Partners with Jeff Goldblum for "RAID: Shadow Legends" in their next Global Advertising Campaign

Retrieved on: 
Friday, December 10, 2021

TEL AVIV, Israel, Dec. 10, 2021 /PRNewswire/ -- Plarium, a global leader in developing F2P mobile and PC games with more than 400 million users worldwide, announced today that actor Jeff Goldblum, star of blockbuster hits, such as; Jurassic Park, Jurassic World, and Independence Day franchises, is leading the next promotional campaign for its popular RAID: Shadow Legends collection RPG. This was the first look at the upcoming campaign which debuted at The Game Awards 2021 in Los Angeles on December 9th, where Goldblum can be seen playing the fantasy collection RPG with childlike delight.

Key Points: 
  • "It was a lot of fun shooting this RAID campaign with the Plarium folks," said Goldblum.
  • "We are honored to have the illustrious Jeff Goldblum, someone we feel is just as much an all-time personality as an actor, become a spokesperson for RAID: Shadow Legends," said Aviram Steinhart, CEO of Plarium.
  • RAID: Shadow Legendsis available to download on iOS and Android mobile devices, as well as PC through the Microsoft Store or the Plarium Play platform.
  • Plarium is part of Pixel United , the global mobile-first games publishing business of Aristocrat Leisure Limited (ASX code: ALL).

Plarium Partners with Jeff Goldblum for "RAID: Shadow Legends" in their next Global Advertising Campaign

Retrieved on: 
Friday, December 10, 2021

TEL AVIV, Israel, Dec. 10, 2021 /PRNewswire/ -- Plarium, a global leader in developing F2P mobile and PC games with more than 400 million users worldwide, announced today that actor Jeff Goldblum, star of blockbuster hits, such as; Jurassic Park, Jurassic World, and Independence Day franchises, is leading the next promotional campaign for its popular RAID: Shadow Legends collection RPG. This was the first look at the upcoming campaign which debuted at The Game Awards 2021 in Los Angeles on December 9th, where Goldblum can be seen playing the fantasy collection RPG with childlike delight.

Key Points: 
  • "It was a lot of fun shooting this RAID campaign with the Plarium folks," said Goldblum.
  • "We are honored to have the illustrious Jeff Goldblum, someone we feel is just as much an all-time personality as an actor, become a spokesperson for RAID: Shadow Legends," said Aviram Steinhart, CEO of Plarium.
  • RAID: Shadow Legendsis available to download on iOS and Android mobile devices, as well as PC through the Microsoft Store or the Plarium Play platform.
  • Plarium is part of Pixel United , the global mobile-first games publishing business of Aristocrat Leisure Limited (ASX code: ALL).

REFIRE Exhibits Clean Power Solutions through the Cloud at Expo 2020 Dubai

Retrieved on: 
Friday, December 10, 2021

This is the first time REFIRE has exhibited its products to global visitors through World Expo's online exhibition.

Key Points: 
  • This is the first time REFIRE has exhibited its products to global visitors through World Expo's online exhibition.
  • REFIRE joined the Expo as a representative of Shanghai's most technologically innovative companies.
  • In line with China's 2060 carbon neutrality goal, REFIRE presented its latest fuel cell technologies that offer clean hydrogen energy solutions for future mobility.
  • Robin Lin, Founder, Chairman and CEO of REFIRE said: "REFIRE is honored to be one of the representative companies of China and Shanghai at the World Expo.